Skip to main content

Security report for biovendor.com

BioVendor – Laboratorni medicina a.s. · Healthcare · Czech Republic

Medium risk. 4 critical or high findings in Security headers, GDPR outside view and 2 other checks.

Security score

61/100

Risk levelMedium

0–100, higher is better. How it is calculated

BioVendor – Laboratorni medicina a.s. operates as a developer and manufacturer of immunoassays, recombinant proteins, antibodies, and endotoxin-removal products, serving laboratories and research institutions globally. The company is part of the BioVendor Group, an international biotechnology conglomerate with multiple specialized subsidiaries. Their business model focuses on B2B sales of in vitro diagnostic products and research reagents, positioning them as a reputable player in the healthcare diagnostics sector. Technically, the website employs a moderate technology stack including jQuery, Slick Carousel, Google Tag Manager, and Microsoft Clarity for analytics and user behavior tracking. The site is well-structured with good mobile optimization and SEO practices, though some technologies like jQuery are outdated, which could pose security risks. Privacy compliance is well addressed with a comprehensive privacy policy and cookie consent mechanisms. From a security perspective, the site uses HTTPS and has implemented cookie consent, but lacks publicly available security policies, incident response plans, and vulnerability disclosure information. The absence of WHOIS data for the domain raises some concerns about domain registration transparency, though the website content and business presence suggest legitimacy. Overall, the security posture is good but could be improved by updating libraries and publishing formal security documentation. The overall risk assessment indicates a trustworthy and professional online presence with minor technical and transparency gaps. Strategic recommendations include enhancing security documentation, updating technical components, and improving accessibility to strengthen compliance and trust further.

Scanned

This is an earlier scan of biovendor.com. View the latest report

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

  4. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • High

      High-Risk Service Exposed: FTP

      Port 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer

      What to do: Consider restricting access to FTP or implementing strong authentication

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

Need hands-on remediation? Email guard@offseq.com

Keep watching biovendor.com

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
65
Email security
70
DNS health
80
Network security
20
GDPR outside view
68
Average
61

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention biovendor.com, from OffSeq Breach.

No leaked records found

Breach holds no records for biovendor.com right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

BioVendor holds a strong market position as an international biotechnology group specializing in immunodiagnostics and molecular biology products. Their competitive advantage lies in a broad product portfolio, including immunoassays, POCT, NGS, and analytical testing services. The company targets research laboratories, clinical diagnostics providers, and healthcare institutions. Revenue streams are diversified across product sales, analytical services, and joint projects with subsidiaries. The partnership ecosystem includes multiple specialized brands and joint ventures, enhancing innovation and market reach. Growth indicators include active participation in international congresses and continuous product launches. The company demonstrates a mature operational model with consistent branding and professional content.

Security posture

The website demonstrates a moderate to good security maturity level with enforced HTTPS and cookie consent mechanisms. However, the use of an outdated jQuery version introduces potential vulnerabilities. The absence of published security policies, incident response procedures, and vulnerability disclosure channels indicates gaps in transparency and preparedness. No exposed sensitive data or obvious vulnerabilities were detected in the HTML content. Compliance with GDPR is evident through privacy policy and data retention disclosures. Overall, the security culture appears functional but would benefit from formalizing policies and updating technical components to mitigate risks.

Recommendations

  1. Publish a dedicated security policy and incident response page to improve transparency and user trust.
  2. Implement a vulnerability disclosure program and security.txt file to facilitate responsible reporting.
  3. Upgrade jQuery and other JavaScript libraries to current versions to reduce security risks.
  4. Add security headers such as Content-Security-Policy and X-Content-Type-Options to enhance protection.
  5. Enhance website accessibility features to comply with standards and improve user experience.

Contact details published on the site

Addresses
Legal name
BioVendor – Laboratorni medicina a.s.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
BioVendor – Laboratorni medicina a.s.
Description
BioVendor Research and Diagnostic Products is a developer and manufacturer of immunoassays, recombinant proteins, antibodies and endotoxin-removal products.
Key services
Immunoassays, POCT, Next Generation Sequencing, Proteins, Antibodies, Immunohistochemistry, Endotoxin Detection & Removal Products, Cell-Based Assays, DNA/RNA Extraction Instruments/Kits, qPCR Kits/Enzymes/Reagents
Content quality
good
Branding
consistent

Technology

Stack
jQuery 1.11.1, Slick Carousel, Google Tag Manager, Microsoft Clarity, Adobe Typekit Fonts
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent banner with opt-in/out
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics (via GTM), Microsoft Clarity
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Microsoft Clarity
Marketing tools
Microsoft Clarity
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and navigation
  2. No WAF or blocking detected
  3. WHOIS data unavailable, indicating possible recent registration or privacy protection
  4. Strong presence of business contact info and privacy compliance
  5. Use of modern marketing and analytics tools with consent mechanisms
  6. No security policy or incident response info publicly available
  7. Technical stack includes older jQuery version which may pose security risks
  8. Good mobile optimization and SEO practices observed
Technical notes

Notes

The website uses a traditional tech stack with jQuery 1.11.1 and Slick Carousel for UI components, supplemented by Google Tag Manager and Microsoft Clarity for analytics and user tracking. Fonts are delivered via Adobe Typekit. The site is mobile responsive with good SEO metadata and structured navigation. Performance is moderate, with no critical errors detected. However, the use of outdated JavaScript libraries suggests technical debt and potential security vulnerabilities. No CMS or hosting provider information was detected. Opportunities exist to modernize the stack, improve accessibility, and implement advanced security headers to reduce risk and improve compliance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 58/100Medium31 findingsView report
Reviews of this site

Share your experience with biovendor.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review biovendor.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.